CEOBand TherapeuticsLexington, Kentucky, United States
OC 08.4 - Aptamer BT200 prolongs VWF half-life by blocking interaction with macrophage scavenger receptor LRP1
Saturday, June 24, 202313:45 – 14:00 ET